As U.S. health officials prepare to authorize Pfizer’s coronavirus vaccine for emergency use in younger children, a new poll shows that less than a third of parents would get their child vaccinated as soon as the shots are approved for kids. Only 29% of parents of children under age 18 said they would get their
(HealthDay)—Outcomes are similar for younger and older adolescents undergoing bariatric surgery, according to a study published online Feb. 1 in Pediatrics. Sarah B. Ogle, D.O., from the University of Colorado in Aurora, and colleagues enrolled 242 adolescents (≤19 years of age) who underwent bariatric surgery in a prospective, multicenter, long-term outcome study. Outcome data, including
Despite being most at risk of contracting COVID-19 and suffering health complications due to the virus, older adults reported feeling calm more often than younger people, and were less likely to report negative emotions like anxiety compared to people their junior, according to a recent study by Stanford psychologist Laura Carstensen. In a survey of
The burden of colorectal cancer is swiftly shifting to younger individuals as incidence increases in young adults and declines in older age groups, according to the latest edition of Colorectal Cancer Statistics 2020, a publication of the American Cancer Society. A sign of the shift: the median age of diagnosis has dropped from age 72
There are three constants in life: death, taxes and ageing (for all of us except J-Lo, obvs). But according to new research, there could be a way to stay young forever… Feel in control. Jennifer Bellingtier, a postdoctoral psychology researcher at Friedrich Schiller University in Germany followed 116 adults aged 60-90 and 106 adults aged
Actor Jaime King is not just a fantastic mom; she’s also an advocate for children, like her son, who have congenital heart defects — and a proponent of affordable health care for all families, not just those as fortunate as hers. She recently shared an update on her younger son Leo’s health battle on social
Premenopausal women with hormone receptor-positive, HER2-negative breast cancer and a high risk of recurrence who are treated with an aromatase inhibitor plus ovarian function suppression may gain 10 to 15 percent improvement in freedom from distant recurrence at eight years, according to a new clinical trial analysis reported at the annual meeting of the American
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok